SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

  Division of General Internal Medicine

[Return To Index page]
photo Douglas P. Landsittel, PhD

Secondary Appointment, Professor of Biostatistics and Clinical and Translational Science

Director, Section on Biomarkers and Prediction Modeling

Director of Biostatistics, Starzl Transplant Institute

Email: landsitteldp@upmc.edu

Phone: 412-864-3019

Contact
Office: 200 Meyran Avenue
Suite 300
Pittsburgh, PA 15213
 
Phone: 412-864-3019
Fax: 412-568-9672
E-mail: landsitteldp@upmc.edu
Education and Training
Education
BS, Applied Mathematics, University of Pittsburgh, 1992
PhD, Biostatistics, University of Pittsburgh, Graduate School of Public Health, 1997
Research Interest
Dr. Landsittel has worked for the last 20 years in the areas of occupational injury and exposures, biomarkers and prognostic models, and more recently causal inference. He is PI of 3 projects, including a data coordinating and imaging analysis center (with KT Bae) for the NIDDK Consortium for Radiological Imaging Studies of PKD (or CRISP), a statistical methods contract from the Patient-Centered Outcomes Research Institute on developing a decision tool for observational CER, and a training and education program in patient-centered outcomes research that is being conducted in partnership with 6 Minority-Serving Institutions. He is also Director of the Section for Biomarkers and Prediction Modeling and Director of Biostatistics for the Starzl Transplant Institute. He is also a faculty member in the Comparative Effectiveness Research Center and the Center for Research on Healthcare. He also collaborates with faculty in Rhuematology, Surgery, and Nephrology.
Educational Interest
Dr. Landsittel is the Director of the CER Track for the Institute for Clinical Research Education, and as such advising a number of trainees from different ICRE programs. He is also the Program Director of Expanding National Capacity in PCOR through Training (ENACT). ENACT is a partnership with the universities of Hawaii and Puerto Rico, Howard and Charles Drew universities, Meharry Medical College, and Morehouse School of Medicine. This collaboration has helped spawn other ICRE programs and is seeking to further develop infrastructure through proposing new clinical trial collaborations, conference presentations, and publications. The ENACT Program includes two online courses, and an experiential program. Dr. Landsittel also teaches several courses in the ICRE, and was formerly involved in both undergraduate mathematics at Duquesne University and teaching graduate courses in the Graduate School of Public Health at Pittsburgh, were he also advises students and oversees PhD students as a secondary faculty.
Publications
For my complete bibliography, Click Here.
Sponsored Research/Activities
Title: Contribution of Follicular Helper T Cell (TFH) and of TREG to DSA Generation After Kidney Transplantation
Role: Co-Investigator
Funding Agency: National Institute of Allergy & Infectious Diseases
Grant Number: R21 AI116746
Start Year: 2016
End Year: 2016
Title: Leading Emerging and Diverse Scientists to Success (LEADS)
Role: Co-Investigator
Funding Agency: National Institute of General Medical Science
Grant Number: R25 GM116740
Start Year: 2015
End Year: 2020
Title: Immune Airway-Epithelial Interactions in Steroid-Refractory Severe Asthma - Core A
Role: Co-Investigator
Funding Agency: National Institute of Allergy & Infectious Diseases
Grant Number: P01 AI106684
Start Year: 2015
End Year: 2020
Title: Expanding National Capacity in PCOR Through Training (ENACT)
Role: Co-Investigator
Funding Agency: Agency for Healthcare Research and Quality
Grant Number: R25 HS023185
Start Year: 2014
End Year: 2019
Title: Modeling Strategies for Observational CER - What Works Best When?
Role: Principal Investigator
Funding Agency: Patient-Centered Outcomes Research Institute
Start Year: 2014
End Year: 2017
Title: T and B Cell Homeostasis After Induction Therapy in Kidney Transplantation
Role: Co-Investigator
Funding Agency: National Institute of Allergy & Infectious Diseases
Grant Number: R01 AI096553
Start Year: 2014
End Year: 2015
Title: Microbubble Contrast-Enhanced Vascular Ultrasonography: A Novel Method of Detecting Large Vessel Vasculitis
Role: Co-Investigator
Funding Agency: Vasculitis Foundation
Start Year: 2014
End Year: 2015
Title: RF, CCP, SSA and More? SSA and Other CTD Autoantibody's Prevalence in African-American Patients with Rheumatoid Arthritis (ASPIRE)
Role: Co-Investigator
Funding Agency: Pfizer Inc.
Start Year: 2013
End Year: 2015
Title: Prognostic Value and Function of IL-33/ST2 in Pediatric Heart Transplant Recipients with Infection
Role: Co-Investigator
Funding Agency: Roche Organ Transplantation Research Foundation
Start Year: 2013
End Year: 2015
Title: Does Teamwork Mediate Relationship between Partner Familiarity and EMT Injuries
Role: Co-Investigator
Funding Agency: National Institute for Occupational Safety and Health
Grant Number: R21 OH010025
Start Year: 2012
End Year: 2014
Title: University of Pittsburgh Clinical and Translational Science Institute - Research Education Core
Role: Co-Investigator
Funding Agency: National Center for Advancing Translational Sciences
Grant Number: UL1 TR000005
Start Year: 2011
End Year: 2016
Title: Mechanisms Linking Hot Flashes to Cardiovascular Risk
Role: Co-Investigator
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: R01 HL105647
Start Year: 2011
End Year: 2016
Title: Consortium for Radiologic Imaging in Polycystic Kidney Disease (CRISP)
Role: Co-Principal Investigator
Funding Agency: National Institute of Diabetes, Digestive, & Kidney Disease
Grant Number: U01 DK056961
Start Year: 2011
End Year: 2016
Title: Validation of Pancreatic Cancer Signature in Retrospective PLCO Samples
Role: Co-Investigator
Funding Agency: National Cancer Institute
Grant Number: U01 CA086402
Start Year: 2011
End Year: 2012
Title: Urine and Serum Biomarkers for Screening and Diagnosis of Ovarian Cancer
Role: Co-Investigator
Funding Agency: National Cancer Institute
Grant Number: R01 CA108990
Start Year: 2010
End Year: 2013
Title: Epithelial PLUNC as a Determinant of Airway Mucosal Antimicrobial Activity
Role: Co-Investigator
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: R01 HL091938
Start Year: 2010
End Year: 2012
Notable Achievements
Member, American Statistical Society, 2013-present